Connection

Philippe Colson to Adult

Back to Details
This is a "connection" page, showing publications Philippe Colson has written about Adult.
Philippe Colson
Connection Strength
0.127
Adult
  1. SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment. Viruses. 2021 05 12; 13(5).
    View in: PubMed
    Score: 0.016
  2. Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: An investigational study. Travel Med Infect Dis. 2021 Mar-Apr; 40:101980.
    View in: PubMed
    Score: 0.015
  3. Temporal and age distributions of SARS-CoV-2 and other coronaviruses, southeastern France. Int J Infect Dis. 2020 Dec; 101:121-125.
    View in: PubMed
    Score: 0.015
  4. Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults. Eur J Clin Microbiol Infect Dis. 2020 Oct; 39(10):1983-1987.
    View in: PubMed
    Score: 0.015
  5. Ocular syphilis, an old adversary is back in the old world too! AIDS. 2018 10 23; 32(16):2433-2434.
    View in: PubMed
    Score: 0.013
  6. Emergence of uncommon HIV-1 non-B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013-2015 period in Marseille, Southeastern France. J Med Virol. 2018 10; 90(10):1559-1567.
    View in: PubMed
    Score: 0.013
  7. Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France. Clin Microbiol Infect. 2021 Oct; 27(10):1516.e1-1516.e6.
    View in: PubMed
    Score: 0.004
  8. COVID-19 re-infection. Eur J Clin Invest. 2021 May; 51(5):e13537.
    View in: PubMed
    Score: 0.004
  9. Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19. J Clin Virol. 2020 12; 133:104682.
    View in: PubMed
    Score: 0.004
  10. Different pattern of the second outbreak of COVID-19 in Marseille, France. Int J Infect Dis. 2021 Jan; 102:17-19.
    View in: PubMed
    Score: 0.004
  11. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
    View in: PubMed
    Score: 0.004
  12. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
    View in: PubMed
    Score: 0.004
  13. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
    View in: PubMed
    Score: 0.004
  14. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949.
    View in: PubMed
    Score: 0.004
  15. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot. Travel Med Infect Dis. 2020 Jul - Aug; 36:101632.
    View in: PubMed
    Score: 0.004
  16. Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis. 2020 Mar - Apr; 34:101624.
    View in: PubMed
    Score: 0.004
  17. Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy. Neurology. 2017 Aug 29; 89(9):909-917.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.